These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 7693877)

  • 1. Laser nephelometric evaluation of albumin, IgG and alpha 2-macroglobulin: applications to the study of alterations of the blood-brain barrier.
    Meucci G; Rossi G; Bettini R; Montanaro D; Gironelli L; Voci L; Bianchi F
    J Neurol Sci; 1993 Aug; 118(1):73-8. PubMed ID: 7693877
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rapid determination of proteins in serum and cerebrospinal fluid by laser-nephelometry.
    Schliep G; Felgenhauer K
    J Clin Chem Clin Biochem; 1978 Nov; 16(11):631-5. PubMed ID: 83350
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The content of the protein markers of hemato-encephalic barrier permeability in the cerebrospinal fluid in severe craniocerebral trauma].
    Kuksinskiĭ VA; Lutsik AA; Churliaev IuA; Lykova OF; Nikiforova NV; Martynenkov VIa; Bykov KV
    Zh Vopr Neirokhir Im N N Burdenko; 1998; (2):26-7. PubMed ID: 9720164
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Blood-brain barrier selectivity and synaptic turnover during delirium tremens and related clinical states. A study of brain and blood proteins in the cerebrospinal fluid.
    Jørgensen OS; Hemmingsen R; Kramp P; Rafaelsen OJ
    Acta Psychiatr Scand; 1980 Apr; 61(4):356-64. PubMed ID: 6160732
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Quantitative determination of 7 proteins in csf of patients with Guillain Barre syndrome].
    Li YT
    Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1990 Oct; 23(5):289-92, 319-20. PubMed ID: 1704305
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proteins as parameters in the discrimination between different blood-CSF barriers.
    Keir G; Thompson EJ
    J Neurol Sci; 1986 Oct; 75(3):245-53. PubMed ID: 2430066
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cerebrospinal fluid and serum levels of albumin, IgG, IgA and IgM in patients with intracranial tumors and lumbar disc herniation.
    Rao ML; Böker DK
    Eur Neurol; 1987; 26(4):241-5. PubMed ID: 3595664
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cerebrospinal fluid protein findings in cervical syndromes classified by myelography, and in multiple sclerosis.
    Ahonen A; Pyhtinen J; Hokkanen E; Myllylä V
    Acta Neurol Scand; 1982 Sep; 66(3):369-77. PubMed ID: 7136499
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of the blood-CSF barrier.
    Statz A; Felgenhauer K
    Dev Med Child Neurol; 1983 Apr; 25(2):152-61. PubMed ID: 6189754
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Determination of immunoglobulins G, A, M, alpha-2-macroglobulin and ceruloplasmin levels in cerebrospinal fluid of children and adults by a nephelometric laser method (author's transl)].
    di Costanzo J; Romette J; Lévy G; Gulian JM; Arnaud C; Ciret P
    Ann Biol Clin (Paris); 1980; 38(4):231-5. PubMed ID: 6160784
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cerebrospinal fluid (CSF) findings in amyotrophic lateral sclerosis.
    Leonardi A; Abbruzzese G; Arata L; Cocito L; Vische M
    J Neurol; 1984; 231(2):75-8. PubMed ID: 6737012
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Age-related changes in cerebrospinal fluid protein concentrations.
    Garton MJ; Keir G; Lakshmi MV; Thompson EJ
    J Neurol Sci; 1991 Jul; 104(1):74-80. PubMed ID: 1717663
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Local immunoglobulin synthesis and blood-brain barrier assessment in subacute sclerosing panencephalitis.
    Silva CA; Rio ME; Cruz C
    Eur Neurol; 1985; 24(2):128-33. PubMed ID: 2579817
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Albumin quotient, IgG concentration, and IgG index determinations in cerebrospinal fluid of neonatal foals.
    Andrews FM; Geiser DR; Sommardahl CS; Green EM; Provenza M
    Am J Vet Res; 1994 Jun; 55(6):741-5. PubMed ID: 7944008
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protein profile of cerebrospinal fluid in multiple sclerosis with special reference to the function of the blood brain barrier.
    Eickhoff K; Wikström J; Poser S; Bauer H
    J Neurol; 1977 Feb; 214(3):207-15. PubMed ID: 65455
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Marker proteins in cerebrospinal fluid of patients with grave craniocerebral injury].
    Kuksinskiĭ VA; Churliaev IuA; Nikiforova NV; Lutsik AA; Lykova OF
    Klin Lab Diagn; 1997 Nov; (11):11-2. PubMed ID: 9471311
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparison between agar gel electrophoresis and CSF serum quotients of IgG and albumin in neurological disease.
    Olsson JE; Pettersson B
    Acta Neurol Scand; 1976 Apr; 53(4):308-22. PubMed ID: 1266574
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CSF and serum concentrations of albumin and IgG in Alzheimer's disease.
    Kay AD; May C; Papadopoulos NM; Costello R; Atack JR; Luxenberg JS; Cutler NR; Rapoport SI
    Neurobiol Aging; 1987; 8(1):21-5. PubMed ID: 3561662
    [TBL] [Abstract][Full Text] [Related]  

  • 19. What determines the CSF concentrations of albumin and plasma-derived IgG?
    Seyfert S; Faulstich A; Marx P
    J Neurol Sci; 2004 Apr; 219(1-2):31-3. PubMed ID: 15050434
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alpha-2-macroglobulin, albumin, and chymotrypsin inhibitory capacity in cerebrospinal fluid as indices of blood-cerebrospinal fluid barrier.
    Rao NR; Pattabiraman TN
    Biochem Med Metab Biol; 1986 Dec; 36(3):317-21. PubMed ID: 2432913
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.